Fingerprint
Dive into the research topics of 'Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Richard E. Pratley, Vanita R. Aroda, Ildiko Lingvay, Jörg Lüdemann, Camilla Andreassen, Andrea Navarria, Adie Viljoen
Research output: Contribution to journal › Article › peer-review